Efficacy and Safety of Neoadjuvant Anlotinib Plus Pemetrexed and Cisplatinum in Patients With Unresectable Stage IIIA Lung Adenocarcinoma
Latest Information Update: 31 Jul 2020
At a glance
- Drugs Catequentinib (Primary) ; Cisplatin (Primary) ; Pemetrexed (Primary)
- Indications Adenocarcinoma; Non-small cell lung cancer
- Focus Therapeutic Use
- 31 Jul 2020 New trial record